Skip to main content

Abarelix Pregnancy and Breastfeeding Warnings

Brand names: Plenaxis

Abarelix Pregnancy Warnings

Abarelix has been assigned to pregnancy category X by the FDA. Animal studies have revealed evidence of embryolethality and fetal resorptions, as well as the a significant decrease in mating and fertility. There are no controlled data in human pregnancy. Abarelix is considered contraindicated during pregnancy.

The significant decrease in mating and fertility in animal studies was reversible.

See references

Abarelix Breastfeeding Warnings

There are no data on the excretion of abarelix into human milk. Because many drugs are excreted in human milk and because the effects of abarelix on lactation and/or the breast-fed child have not been determined, abarelix should not be used by nursing mothers.

See references

References for pregnancy information

  1. Product Information. Plenaxis (abarelix). Praecis Pharmaceuticals Inc. 2003.

References for breastfeeding information

  1. Product Information. Plenaxis (abarelix). Praecis Pharmaceuticals Inc. 2003.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer